NCT02218346View on ClinicalTrials.gov

Food Effect Study of AG-221 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

March 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

AG221

AG221 in fed and fasted conditions

Trial Locations (1)

21225

Baltimore

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

Agios Pharmaceuticals, Inc.

INDUSTRY